Lumibird

LBIRD.PA Small Cap

Healthcare · Diagnostics & Research

Updated: Apr 5, 2026, 17:43 UTC

€21.70

-0.46% today

52W: €8.14 – €24.50

52W Low: €8.14 Position: 82.9% 52W High: €24.50

🔗 Compare Brokers

Key Metrics

P/E Ratio

45.21x

Price-to-Earnings

Forward P/E

17.36x

Forward Price/Earnings

P/S Ratio

2.12x

Price-to-Sales

EV/EBITDA

—

Enterprise Value/EBITDA

Div. Yield

—

Annual dividend yield

Market Cap

$477.9M

Market Capitalization

Revenue Growth

5.9%

YoY Revenue Growth

Profit Margin

6.21%

Net profit margin

ROE

6.93%

Return on Equity

Beta

0.87

Market sensitivity

Short Interest

—

% of float sold short

Avg. Volume

32,051

Average daily volume

Valuation Analysis

Signal

Overvalued

vs. S&P 500 avg P/E (24.7x)

Analyst Consensus

None

2 analysts

Avg. Price Target

€28.40

+30.88% upside

Target Range

€28.30 – €28.50

About the Company

Lumibird SA designs, manufactures, and sells various lasers for scientific, industrial, and medical applications. It operates in two divisions, Photonics and Medical. The company offers solid-state lasers, laser diodes and components, fiber lasers and amplifiers, and high-power fiber lasers; and doppler wind LiDAR, time-of-flight LiDAR and rangefinders, military lasers rangefinders, and medical and ophthalmological solutions. Its products are used in various applications, such as defense and space, environment, topography and safety, industry and science, and science and healthcare industries. The company was incorporated in 1970 and is headquartered in Lannion, France. Lumibird SA is a subsidiary of ESIRA.

Sector: Healthcare Industry: Diagnostics & Research Country: France Exchange: PAR